These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25007784)

  • 1. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing.
    Steppe M; Van Nieuwerburgh F; Vercauteren G; Boyen F; Eeckhaut V; Deforce D; Haesebrouck F; Ducatelle R; Van Immerseel F
    Food Chem Toxicol; 2014 Oct; 72():129-37. PubMed ID: 25007784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model.
    Geirnaert A; Wang J; Tinck M; Steyaert A; Van den Abbeele P; Eeckhaut V; Vilchez-Vargas R; Falony G; Laukens D; De Vos M; Van Immerseel F; Raes J; Boon N; Van de Wiele T
    FEMS Microbiol Ecol; 2015 Jun; 91(6):. PubMed ID: 25999470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions.
    Geirnaert A; Steyaert A; Eeckhaut V; Debruyne B; Arends JB; Van Immerseel F; Boon N; Van de Wiele T
    Anaerobe; 2014 Dec; 30():70-4. PubMed ID: 25179909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of
    Boesmans L; Valles-Colomer M; Wang J; Eeckhaut V; Falony G; Ducatelle R; Van Immerseel F; Raes J; Verbeke K
    mSystems; 2018; 3(6):. PubMed ID: 30417112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyricicoccus pullicaecorum in inflammatory bowel disease.
    Eeckhaut V; Machiels K; Perrier C; Romero C; Maes S; Flahou B; Steppe M; Haesebrouck F; Sas B; Ducatelle R; Vermeire S; Van Immerseel F
    Gut; 2013 Dec; 62(12):1745-52. PubMed ID: 23263527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of gastrointestinal behavior of Butyricicoccus pullicaecorum, a novel butyrate producing isolate with probiotic potential to counterbalance dysbiosis in inflammatory bowel disease.
    Geirnaert A; Steyaert A; Van den Abbeele P; Eeckhaut V; Van Immerseel F; Boon N; Van de Wiele T
    Commun Agric Appl Biol Sci; 2013; 78(1):157-63. PubMed ID: 23875313
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety Assessment of Lactobacillus helveticus KLDS1.8701 Based on Whole Genome Sequencing and Oral Toxicity Studies.
    Li B; Jin D; Etareri Evivie S; Li N; Yan F; Zhao L; Liu F; Huo G
    Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28946645
    [No Abstract]   [Full Text] [Related]  

  • 8. Butyricicoccus pullicaecorum gen. nov., sp. nov., an anaerobic, butyrate-producing bacterium isolated from the caecal content of a broiler chicken.
    Eeckhaut V; Van Immerseel F; Teirlynck E; Pasmans F; Fievez V; Snauwaert C; Haesebrouck F; Ducatelle R; Louis P; Vandamme P
    Int J Syst Evol Microbiol; 2008 Dec; 58(Pt 12):2799-802. PubMed ID: 19060061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Probiotic
    Eeckhaut V; Wang J; Van Parys A; Haesebrouck F; Joossens M; Falony G; Raes J; Ducatelle R; Van Immerseel F
    Front Microbiol; 2016; 7():1416. PubMed ID: 27708624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study.
    Salvetti E; Orrù L; Capozzi V; Martina A; Lamontanara A; Keller D; Cash H; Felis GE; Cattivelli L; Torriani S; Spano G
    Appl Microbiol Biotechnol; 2016 May; 100(10):4595-605. PubMed ID: 26952108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety evaluation of two bacterial strains used in Asian probiotic products.
    Tompkins TA; Hagen KE; Wallace TD; Fillion-Forté V
    Can J Microbiol; 2008 May; 54(5):391-400. PubMed ID: 18449224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.
    Geirnaert A; Calatayud M; Grootaert C; Laukens D; Devriese S; Smagghe G; De Vos M; Boon N; Van de Wiele T
    Sci Rep; 2017 Sep; 7(1):11450. PubMed ID: 28904372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gut butyrate-producing bacterium
    Chang SC; Shen MH; Liu CY; Pu CM; Hu JM; Huang CJ
    Oncol Lett; 2020 Dec; 20(6):327. PubMed ID: 33101496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inulin-type fructan degradation capacity of Clostridium cluster IV and XIVa butyrate-producing colon bacteria and their associated metabolic outcomes.
    Moens F; De Vuyst L
    Benef Microbes; 2017 May; 8(3):473-490. PubMed ID: 28548573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463.
    Senan S; Prajapati JB; Joshi CG
    Probiotics Antimicrob Proteins; 2015 Dec; 7(4):249-58. PubMed ID: 26223907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome based safety assessment for Bacillus coagulans strain LBSC (DSM 17654) for probiotic application.
    Saroj DB; Gupta AK
    Int J Food Microbiol; 2020 Apr; 318():108523. PubMed ID: 31964505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of the upper gastrointestinal passage of a novel butyrate producing isolate to counterbalance dysbiosis in inflammatory bowel disease.
    Geirnaert A; Debruyne B; Eeckhaut V; Van Immerseel F; Boon N; Van de Wiele T
    Commun Agric Appl Biol Sci; 2012; 77(1):195-9. PubMed ID: 22558780
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo.
    Isa K; Oka K; Beauchamp N; Sato M; Wada K; Ohtani K; Nakanishi S; McCartney E; Tanaka M; Shimizu T; Kamiya S; Kruger C; Takahashi M
    Hum Exp Toxicol; 2016 Aug; 35(8):818-32. PubMed ID: 26437792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of Lactobacillus plantarum JDM1 based on the complete genome.
    Zhang ZY; Liu C; Zhu YZ; Wei YX; Tian F; Zhao GP; Guo XK
    Int J Food Microbiol; 2012 Feb; 153(1-2):166-70. PubMed ID: 22133564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.